Salta al contenuto principale
Passa alla visualizzazione normale.

GIORGIO STASSI

Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging

  • Autori: Tirinato, L.; Liberale, C.; DI FRANCO, S.; Candeloro, P.; Benfante, A.; La Rocca, R.; Potze, L.; Marotta, R.; Ruffilli, R.; Rajamanickam, V.; Malerba, M.; De Angelis, F.; Falqui, A.; Carbone, E.; Todaro, M.; Medema, J.; Stassi, G.; Di Fabrizio, E.
  • Anno di pubblicazione: 2015
  • Tipologia: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/122257

Abstract

The Cancer Stem Cell (CSC) model is describing tumors as a hierarchical organized system and CSCs are suggested to be responsible for cancer recurrence after therapy. The identification of specific markers of CSCs is therefore of paramount importance. Here we show that high levels of Lipid Droplets (LDs) are a distinctive mark of CSCs in colorectal (CR) cancer. This increased lipid content was clearly revealed by label free Raman spectroscopy and it directly correlates with well‐accepted CR‐CSCs markers as CD133 and Wnt pathway activity. By xenotransplantation experiments, we have finally demonstrated that CR‐CSCs overexpressing LDs retain most tumorigenic potential. A relevant conceptual advance in this work is the demonstration that a cellular organelle, the Lipid Droplet, is a signature of CSCs, in addition to molecular markers. A further functional characterization of LDs could lead soon to design new target therapies against CR‐CSCs.